Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Liver histology results for Innogenetics' E1 therapeutic vaccine for HCV

Oct. 22, 2002

Pegasys approved by FDA

Oct. 21, 2002

Antisense oligonucleotide to ICAM-1 ameliorates chronic intestinal inflammation in transgenic rats

Oct. 21, 2002

GSK researchers identify novel inhibitors of TGF-beta type I (ALK5) receptor

Oct. 17, 2002

InterMune and Inhale to develop PEGylated Infergen

Oct. 16, 2002

Inhibitors of TGF-beta signaling pathway described in GSK patent

Oct. 14, 2002

Phosphonate nucleotide and its oral prodrug with potent, selective anti-HBV activity

Oct. 11, 2002

Ulcerative colitis drug TC-2403-12 completes phase I

Oct. 10, 2002

Small-molecule HCV therapeutics sought in Enanta-Chiron collaboration

Oct. 7, 2002

Novel inhibitors of HCV NS3 protease in BMS pipeline

Oct. 4, 2002

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...